RESMED INC — Director's Dealing 2011

Nov 10, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-11-09

Reporting Person: PENDARVIS DAVID (Chief Admin Off. & Gen.Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-11-09	ResMed Common Stock	M	4756	$21.025	Acquired	52699.086	Direct
2011-11-09	ResMed Common Stock	M	16040	$12.468	Acquired	68739.086	Direct
2011-11-09	ResMed Common Stock	M	10388	$19.250	Acquired	79127.086	Direct
2011-11-09	ResMed Common Stock	M	43426	$6.908	Acquired	122553.086	Direct
2011-11-09	ResMed Common Stock	M	10692	$9.350	Acquired	133245.086	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-11-09	ResMed Common Stock Options	$21.025	M	4756	Disposed	2014-11-07	ResMed Common Stock (4756)	Direct
2011-11-09	ResMed Common Stock Options	$12.468	M	16040.000	Disposed	2015-01-20	ResMed Common Stock (16040)	Direct
2011-11-09	ResMed Common Stock Options	$19.250	M	10388	Disposed	2016-02-03	ResMed Common Stock (10388)	Direct
2011-11-09	ResMed Common Stock Options	$6.9075	M	43426	Disposed	2012-10-01	ResMed Common Stock (43426)	Direct
2011-11-09	ResMed Common Stock Options	$9.350	M	10692	Disposed	2013-05-27	ResMed Common Stock (10692)	Direct

Footnotes

F1: Represents date options first became exercisable.

F2: Includes 384.199 shares of common stock purchased on October 31, 2011, pursuant to ResMed's Employee Stock Purchase Plan.